We suggest that inhibition of translation by miRNAs is an important mechanism regulating utrophin expression and that it could be targeted as a therapeutic strategy to upregulate utrophin in the myofiber in DMD. This evidence concerns the gene UTRN and Duchenne muscular dystrophy.